pentobarbital will reduce the extent or effect of buprenorphine, extended-performing injection by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Sufferers who transfer to buprenorphine extensive-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored